Diagnostic News and Research

RSS

Organizing the Nano World Cancer Day: A European multi-sites event in Paris, Braga and Berlin

In the framework of the World Cancer Day, the European Technology Platform of Nanomedicine (ETPN) and its partners will organize a European event on February the 1st on "How nanomedicine contributes to better cancer diagnostic and therapy". Similar and simultaneous events will be organized in France and Portugal, highlighting the importance of nanomedicine research for cancer on the European level.

31 Jan 2013

SGO proposes new ways to deliver high quality, cost-effective gynecologic cancer care

The Society of Gynecologic Oncology (SGO) today proposed new ways to deliver high quality, cost-effective care to women with gynecologic cancers.

31 Jan 2013

Performing angiography and cardiac surgery on the same day increases risk of acute kidney injury

Performing heart surgery on the same day as angiography is now confirmed as a risk factor for acute kidney injury (AKI), and hospital policy limiting the practice for elective cardiac surgery has significantly reduced the rate of AKI, according to a study published in the February 2013 issue of The Annals of Thoracic Surgery.

31 Jan 2013

Vaccine confidence: an interview with Dr Heidi Larson

Here at the London School of Hygiene and Tropical Medicine we are running a project called the Vaccine Confidence Project and we have a global surveillance monitoring information around the world on media, social media, all sorts of information, reports from governments, UN, other sources, looking for any what we call “signals” of public distrust or concerns that come up.

30 Jan 2013

Clarient adopts QIAGEN’s therascreen KRAS test to diagnose colorectal cancer

QIAGEN N.V. today announced that Clarient - a GE Healthcare Company and leading provider of cancer laboratory testing services in the United States - has adopted the use of the therascreen KRAS RGQ PCR Kit (therascreen KRAS test) as a companion diagnostic to guide the use of Erbitux (cetuximab) as a treatment in patients with metastatic colorectal cancer.

From QIAGEN Manchester Limited 30 Jan 2013

Study finds negligible effect on periprocedural outcomes among patients after spine surgery

The "July effect"-the notion that the influx of new residents and fellows at teaching hospitals in July of each year adversely affects patient care and outcomes-was examined in a very large data set of hospitalizations for patients undergoing spine surgery. Researchers at the Mayo Clinic and the University of Virginia Health System found a negligible effect on periprocedural outcomes among patients treated by spine surgery.

30 Jan 2013

One-step, off-the-shelf tool can help evaluate genetic cause of mitochondrial diseases

More powerful gene-sequencing tools have increasingly been uncovering disease secrets in DNA within the cell nucleus. Now a research team is expanding those rapid next-generation sequencing tests to analyze a separate source of DNA—within the genes inside mitochondria, cellular power plants that, when abnormal, contribute to complex, multisystem diseases.

29 Jan 2013

New genetic test can help identify small aggressive lung tumors linked with poor survival

A novel genetic test can help identify small but aggressive lung tumors associated with poor survival, according to a study released today at the 49th Annual Meeting of The Society of Thoracic Surgeons held at the Los Angeles Convention Center.

29 Jan 2013

DRCRF announces recipients of Nov. 2012 Damon Runyon Fellows

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named 15 new Damon Runyon Fellows at its fall Fellowship Award Committee review.

29 Jan 2013

Karmanos Cancer Institute’s SoftVue system under FDA review for market clearance

SoftVue, the whole breast ultrasound imaging device created by two scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, is currently undergoing review by the U.S. Food and Drug Administration (FDA) for market clearance.

29 Jan 2013

Researchers investigate acidity in solid tumors to determine if pH levels play a role in cell invasion

Researchers at Moffitt Cancer Center and colleagues at Wayne State University School of Medicine investigated the acidity in solid tumors to determine if pH levels play a role in cancer cell invasion in surrounding tissues.

28 Jan 2013

Millennium, Seattle Genetics commence ADCETRIS plus chemotherapy phase III trial in MTCL

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the initiation of a global phase III clinical trial evaluating ADCETRIS (brentuximab vedotin) in combination with chemotherapy for the treatment of newly diagnosed CD30-positive mature T-cell lymphoma (MTCL) patients, including patients with systemic anaplastic large cell lymphoma (sALCL) and other types of peripheral T-cell lymphomas.

28 Jan 2013

Alzheimer's Association, SNMMI publish appropriate use criteria for brain amyloid imaging with PET

Only recently has it become possible to create high-quality images of the brain plaques characteristic of Alzheimer's disease in living people through positron emission tomography (PET). Even so, questions remain about what can be learned from these PET images and which people should have this test.

28 Jan 2013

UMDNJ-School of Osteopathic Medicine to develop blood test that can diagnose MCI

The Biomarker Discovery Center at the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine has been awarded a three-year, $799,800 grant from the Osteopathic Heritage Foundation to develop a blood test that can diagnose mild cognitive impairment (MCI) caused by early-stage Alzheimer's disease.

28 Jan 2013

Carmenta acquires option to license Stanford technology for preeclampsia diagnostic test

Carmenta Bioscience, Inc., a privately held medical technology company focused on maternal and fetal health, today announced it has acquired the option for a worldwide, exclusive license from Stanford University to develop a set of tests enabling physicians to better diagnose and predict preeclampsia.

28 Jan 2013

Toshiba enters agreement to acquire majority shares of TMST

Toshiba Medical Systems Corporation, a group company of Toshiba Corporation, today announced that it has entered into an agreement to acquire a majority shares of the stock of a distributor in Turkey, TMST Tıbbi Sistemler Pazarlama Ticaret ve Servis A.S. handling medical diagnostic imaging systems sales and services of TMSC products in Turkish market.

28 Jan 2013

FDA updates metal-on-metal hip replacement advice

The US Food and Drug Administration has updated its advice on the use of metal-on-metal hip replacement prostheses.

25 Jan 2013

Semantic priming abnormalities differ between bipolar disorder and schizophrenia

Patients with bipolar disorder have decreased semantic priming, the results of a preliminary study indicate.

25 Jan 2013

Vejthani ART Center provides innovative and high quality services

Vejthani Hospital Bangkok recommends Assisted Reproductive Technology Center at Vejthani ART Center, the way to bring your dream come true that you will be assured by our professional service.

25 Jan 2013

Subsidised antimalarial drugs: an interview with Kara Hanson

Artemisinin-based combination therapies (ACTs) are the currently recommended drugs for treating malaria. However, they are expensive, which limits their affordability. This means that people with malaria are likely to buy cheaper, less effective antimalarials such as chloroquine and sulphadoxine-pyrimethamine; or to simply buy painkillers and antipyretics.

25 Jan 2013

Diagnostic News and Research

Organizing the Nano World Cancer Day: A European multi-sites event in Paris, Braga and Berlin

SGO proposes new ways to deliver high quality, cost-effective gynecologic cancer care

Performing angiography and cardiac surgery on the same day increases risk of acute kidney injury

Vaccine confidence: an interview with Dr Heidi Larson

Clarient adopts QIAGEN’s therascreen KRAS test to diagnose colorectal cancer

Study finds negligible effect on periprocedural outcomes among patients after spine surgery

One-step, off-the-shelf tool can help evaluate genetic cause of mitochondrial diseases

New genetic test can help identify small aggressive lung tumors linked with poor survival

DRCRF announces recipients of Nov. 2012 Damon Runyon Fellows

Karmanos Cancer Institute’s SoftVue system under FDA review for market clearance

Researchers investigate acidity in solid tumors to determine if pH levels play a role in cell invasion

Millennium, Seattle Genetics commence ADCETRIS plus chemotherapy phase III trial in MTCL

Alzheimer's Association, SNMMI publish appropriate use criteria for brain amyloid imaging with PET

UMDNJ-School of Osteopathic Medicine to develop blood test that can diagnose MCI

Carmenta acquires option to license Stanford technology for preeclampsia diagnostic test

Toshiba enters agreement to acquire majority shares of TMST

FDA updates metal-on-metal hip replacement advice

Semantic priming abnormalities differ between bipolar disorder and schizophrenia

Vejthani ART Center provides innovative and high quality services

Subsidised antimalarial drugs: an interview with Kara Hanson

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News